Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles

Physiologically stable multimodality imaging probes for positron emission tomography/single-photon emission computed tomography (PET/SPECT)-magnetic resonance imaging (MRI) were synthesized using the superparamagnetic maghemite iron oxide (γ-Fe2O3) nanoparticles (SPIONs). The SPIONs were sterically stabilized with a finely tuned mixture of diblock copolymers with either methoxypolyethylene glycol (MPEG) or primary amine NH2 end groups. The radioisotope for PET or SPECT imaging was incorporated with the SPIONs at high temperature. 57Co2+ ions with a long half-life of 270.9 days were used as a model for the radiotracer to study the kinetics of radiolabeling, characterization, and the stability of the radiolabeled SPIONs. Radioactive 67Ga3+ and Cu2+-labeled SPIONs were also produced successfully using the optimized conditions from the 57Co2+-labeling process. No free radioisotopes were detected in the aqueous phase for the radiolabeled SPIONs 1 week after dispersion in phosphate-buffered saline (PBS). All labeled SPIONs were not only well dispersed and stable under physiological conditions but also noncytotoxic in vitro. The ability to design and produce physiologically stable radiolabeled magnetic nanoparticles with a finely controlled number of functionalizable end groups on the SPIONs enables the generation of a desirable and biologically compatible multimodality PET/SPECT-MRI agent on a single T2 contrast MRI probe.

[1]  Daisuke Takenaka,et al.  High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. , 2014, Radiology.

[2]  Jan Grimm,et al.  Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle , 2014, Nature Communications.

[3]  Ick Chan Kwon,et al.  In vivo targeted delivery of nanoparticles for theranosis. , 2011, Accounts of chemical research.

[4]  B. Hamm,et al.  Modification of Aminosilanized Superparamagnetic Nanoparticles: Feasibility of Multimodal Detection Using 3T MRI, Small Animal PET, and Fluorescence Imaging , 2009, Molecular Imaging and Biology.

[5]  J. E. Lier,et al.  The use of SEP-PAK Sl cartridges for the preparation of gallium chloride from the citrate solution , 1993, European Journal of Nuclear Medicine.

[6]  Jan Grimm,et al.  Nanoparticles for imaging: top or flop? , 2014, Radiology.

[7]  Brian S. Hawkett,et al.  The composition and end-group functionality of sterically stabilized nanoparticles enhances the effectiveness of co-administered cytotoxins. , 2013, Biomaterials science.

[8]  Albert J Sinusas,et al.  Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features , 2015, The Journal of Nuclear Medicine.

[9]  Brian S. Hawkett,et al.  The interaction of sterically stabilized magnetic nanoparticles with fresh human red blood cells , 2015, International journal of nanomedicine.

[10]  R. Weissleder,et al.  Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles , 2006, Nature Protocols.

[11]  Alice M. Bowen,et al.  Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c4sc02778g Click here for additional data file. , 2014, Chemical science.

[12]  Andrea Protti,et al.  (⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. , 2011, Bioconjugate chemistry.

[13]  Georges El Fakhri,et al.  Heat-Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET. , 2015, Angewandte Chemie.

[14]  Jenn‐Shing Chen,et al.  A specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imaging. , 2010, Biomaterials.

[15]  K. Herrmann,et al.  68Gallium- and 90Yttrium-/177Lutetium: “theranostic twins” for diagnosis and treatment of NETs , 2014, Annals of Nuclear Medicine.

[16]  Scott C. Brown,et al.  Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives , 2011, Analytical and bioanalytical chemistry.

[17]  Claudia Calcagno,et al.  Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. , 2008, Nano letters.

[18]  Ralph Weissleder,et al.  A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. , 2003, Cancer research.

[19]  Brian S. Hawkett,et al.  Ultrasmall superparamagnetic iron oxide nanoparticle prelabelling of human neural precursor cells. , 2014, Biomaterials.

[20]  Vincenzo Di Lazzaro,et al.  Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation , 2014, Investigative radiology.

[21]  Konstantin Nikolaou,et al.  25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives , 2016, Advances in Therapy.

[22]  B. Pichler,et al.  Pre-clinical PET/MR: technological advances and new perspectives in biomedical research , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  Wei Liu,et al.  Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation , 2009, Journal of Translational Medicine.

[24]  Greg M Thurber,et al.  18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.

[25]  C. Anderson,et al.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. , 2010, Chemical reviews.

[26]  Brian S. Hawkett,et al.  Synthesis of polymeric janus nanoparticles and their application in surfactant-free emulsion polymerizations , 2015 .

[27]  Jenn‐Shing Chen,et al.  Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. , 2009, Biomaterials.